1,102
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer

, , , , , , , & show all
Article: e1138200 | Received 23 Sep 2015, Accepted 29 Dec 2015, Published online: 22 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yinyu Mu, Fuyi Xie, Dongdong Yang & Guodong Xu. (2022) CircRNA6783 Inhibits Cell Proliferation and Promotes Apoptosis in Lung Adenocarcinoma. Cancer Management and Research 14, pages 1229-1236.
Read now
Yukimune Kanehira, Kohei Togami, Kiyomi Ishizawa, Shingo Sato, Hitoshi Tada & Sumio Chono. (2019) Intratumoral delivery and therapeutic efficacy of nanoparticle-encapsulated anti-tumor siRNA following intrapulmonary administration for potential treatment of lung cancer. Pharmaceutical Development and Technology 24:9, pages 1095-1103.
Read now
Lei Shen, Xiaoguang Wu, Jinjing Tan, Meng Gu, Yu Teng, Zitong Wang & Wentao Yue. (2017) Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer. OncoTargets and Therapy 10, pages 3545-3556.
Read now

Articles from other publishers (19)

Bryan Gosselin, Maurice Retout, Ivan Jabin & Gilles Bruylants. (2024) Development of a peptide-based lateral flow assay for the detection of the cancer biomarker Mdm2. Sensors & Diagnostics.
Crossref
Keyan Wang, Cuipeng Qiu, Mengtao Xing, Miao Li, Bofei Wang, Hua Ye, Jianxiang Shi, Liping Dai, Xiao Wang & Peng Wang. (2023) Association of elevated autoantibody to high expression of GNAS in hepatocellular carcinoma. Heliyon 9:12, pages e22627.
Crossref
Jolanta Smok-Kalwat, Paulina Mertowska, Sebastian Mertowski, Konrad Smolak, Aleksandra Kozińska, Filip Koszałka, Wojciech Kwaśniewski, Ewelina Grywalska & Stanisław Góźdź. (2023) The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer. International Journal of Molecular Sciences 24:2, pages 1506.
Crossref
Sasha Patil, Farhadul Islam & Vinod Gopalan. 2023. Cancer Stem Cells: Basic Concept and Therapeutic Implications. Cancer Stem Cells: Basic Concept and Therapeutic Implications 325 347 .
Hong Huang, Yongfeng Yang, Yihan Zhu, Hongyu Chen, Ying Yang, Li Zhang & Weimin Li. (2022) Blood protein biomarkers in lung cancer. Cancer Letters 551, pages 215886.
Crossref
Xue Zhang, Jiaqi Li, Yulin Wang, Man Liu, Fenghui Liu, Xiuzhi Zhang, Lu Pei, Tingting Wang, Di Jiang, Xiao Wang, Jianying Zhang & Liping Dai. (2022) A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma. Frontiers in Immunology 12.
Crossref
Ping Chen, Wei Lu & Tingting Chen. (2021) Seven tumor‐associated autoantibodies as a serum biomarker for primary screening of early‐stage non‐small cell lung cancer. Journal of Clinical Laboratory Analysis.
Crossref
Zhi-Dan Hua, Xian-Bing Liu, Jian-Hui Sheng, Chao Li, Ping Li, Xiu-Qin Cai & Zhi-Qiang Han. (2021) UBE2V2 Positively Correlates With PD-L1 Expression and Confers Poor Patient Survival in Lung Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology 29:8, pages 585-591.
Crossref
Halin Bareke, Pablo Juanes-Velasco, Alicia Landeira-Viñuela, Angela-Patricia Hernandez, Juan Jesús Cruz, Lorena Bellido, Emilio Fonseca, Alfonssina Niebla-Cárdenas, Enrique Montalvillo, Rafael Góngora & Manuel Fuentes. (2021) Autoimmune Responses in Oncology: Causes and Significance. International Journal of Molecular Sciences 22:15, pages 8030.
Crossref
Xiuzhi Zhang, Man Liu, Xue Zhang, Yulin Wang & Liping Dai. 2021. 1 45 .
Yinyu Mu, Fuyi Xie & Tingting Sun. (2020) Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer. Journal of Clinical Laboratory Analysis 34:8.
Crossref
Di Jiang, Yulin Wang, Man Liu, Qiufang Si, Tingting Wang, Lu Pei, Peng Wang, Hua Ye, Jianxiang Shi, Xiao Wang, Chunhua Song, Kaijuan Wang, Liping Dai & Jianying Zhang. (2020) A panel of autoantibodies against tumor-associated antigens in the early immunodiagnosis of lung cancer. Immunobiology 225:1, pages 151848.
Crossref
Bin Yang, Xiaoyan Li, Tianyi Ren & Yiyu Yin. (2019) Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review. Cell Death Discovery 5:1.
Crossref
Chihiro Inoue, Ryoko Saito, Wataru Nakanishi, Hiroyuki Kumata, Shunsuke Eba, Fumiyoshi Fujishima, Mika Watanabe & Hironobu Sasano. (2019) Renal Epithelioid Angiomyolipoma Undergoing Aggressive Clinical Outcome: The MDM2 Expression in Tumor Cells of Two Cases. The Tohoku Journal of Experimental Medicine 247:2, pages 119-127.
Crossref
Shahid Hussain, Sonal Saxena, Sameer Shrivastava, Richa Arora, Rajkumar James Singh, Subas Chandra Jena, Naveen Kumar, Anil Kumar Sharma, Monalisa Sahoo, Ashok Kumar Tiwari, Bishnu Prasad Mishra & Raj Kumar Singh. (2018) Multiplexed Autoantibody Signature for Serological Detection of Canine Mammary Tumours. Scientific Reports 8:1.
Crossref
Ling Wu, Hailin Tang, Shengqiang Hu, Yonghong Xia, Zhixuan Lu, Yujuan Fan, Zixiao Wang, Xinyao Yi, Feimeng Zhou & Jianxiu Wang. (2018) Sensitive and simultaneous surface plasmon resonance detection of free and p53-bound MDM2 proteins from human sarcomas. The Analyst 143:9, pages 2029-2034.
Crossref
Jing Wu, Xiaobo Li, Wuqi Song, Yong Fang, Li Yu, Siyuan Liu, Leonid P. Churilov & Fengmin Zhang. (2017) The roles and applications of autoantibodies in progression, diagnosis, treatment and prognosis of human malignant tumours. Autoimmunity Reviews 16:12, pages 1270-1281.
Crossref
Pei Li, Jian-Xiang Shi, Meng-Tao Xing, Li-Ping Dai, Ji-Tian Li & Jian-Ying Zhang. (2017) Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Tumor Biology 39:10, pages 101042831771166.
Crossref
Hao Sun, Jian-Xiang Shi, Hong-Fei Zhang, Meng-Tao Xing, Pei Li, Li-Ping Dai, Cheng-Lin Luo, Xiao Wang, Peng Wang, Hua Ye, Liu-Xia Li & Jian-Ying Zhang. (2017) Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer. Tumor Biology 39:6, pages 101042831769913.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.